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PURPOSE. To define the phenotype of C2orf71 associated retinopathy and to present novel
mutations in this gene.
METHODS. A retrospective multicenter study of patients with retinopathy and identified
C2orf71 mutations was performed. Ocular function (visual acuity, visual fields, electroret-
inogram [ERG] responses); retinal morphology (fundus, optical coherence tomography); and
underlying mutations were analyzed.
RESULTS. Thirteen patients from 11 families, who were aged 7 to 63 years (mean: 32.1 years) at
their first examination with presumed compound heterozygous (6/13 patients) or
homozygous (7/13 patients) C2orf71 mutations were identified. Eight of the mutations were
novel. Truncation mutations were responsible in all cases. Nyctalopia was observed in less
than 50% of patients. Visual acuity ranged from 20/20 to light perception. Severe visual loss
was associated with atrophic maculopathy. Full-field ERG responses showed severe
progressive cone-rod or rod-cone dysfunction. Typical fundus changes were progressive
symmetrical retinopathy with an early mild maculopathy and patchy circular midperipheral
RPE atrophy. Normal retinal lamination was preserved despite early disruption of the ellipsoid
zone and RPE irregularities. Outer retinal tubulations were associated with better-preserved
visual acuity.
CONCLUSIONS. On the basis of our multicenter analysis, C2orf71 might represent a more
frequently mutated gene in autosomal recessive retinitis pigmentosa in some populations. The
phenotype analysis over a wide age range showed a variable and progressive retinal
degeneration with early onset maculopathy and a better visual potential before the age of 30
years.
Keywords: C2orf71 gene, retinitis pigmentosa, phenotype, outer retinal tubulation
The human gene C2orf71 consists of two exons and codesfor an open reading frame of 1288 amino acid residues.
Expression studies in the Zebrafish model showed that the
protein is localized in primary cilia. This could be suggestive for
a role of the protein in the outer segments of photoreceptor
cells or in the connecting cilium.1
Mutations in C2orf71 were first described in 2010 in six
patients with nonsyndromic, autosomal-recessive retinitis
pigmentosa (arRP) and two patients with early onset retinal
dystrophy with nystagmus.1 The current total number of
mutations in the Human Gene Mutation Database (HGMD) is
35 (13 missense, 11 nonsense, 9 small deletions, 1 insertion,
and 1 insertion/deletion). In the majority of patients, mutations
lead to RP, but other phenotypes (such as cone-rod dystrophy)
have also been reported. The frequency of C2orf71 mutations
and related phenotypes appear to vary between populations.
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For example, in Swiss patients with retinal dystrophies, the
frequency of pathogenic sequence variations in C2orf71is
15%,2 but it is only 1% in French patients with autosomal-
recessive RP.3 Audo et al.3 identified two patients with marked
macular atrophy and severe retinal dysfunction at age 34 and
44 years. Collin et al.4 reported a phenotype of RP with early
onset cone dysfunction in one family of four affected
individuals between 30 and 37 years old, while two other
families showed ‘‘typical signs of RP’’ and severe retinal
dysfunction. Since then, isolated or familial cases with C2orf71
mutations associated with a RP phenotype have been
documented.5–11
In this study, we present the clinical and genetic findings in
the largest cohort to date of 13 patients with a wide age range
and eight novel mutations in order to better characterize
C2orf71-associated phenotypes.
METHODS
This is a retrospective multicenter study, which was approved
by the respective ethics board of each institution and met the
tenets of the Declaration of Helsinki. Data were collected from
six different institutions. The inclusion criterion was the
clinically approved molecular diagnosis of presumably patho-
genic C2orf71 mutations in individuals affected with retinal
dysfunction.
Ocular Function and Morphology
All subjects had attended an ocular genetics clinic and received
an eye examination, including dilated fundus examination;
visual acuity (VA) measurement using Snellen or Early
Treatment Diabetic Retinopathy Study (ETDRS) charts; fundus
photography and fundus autofluorescence (FAF; Spectralis;
Heidelberg Engineering, Heidelberg, Germany; VisucamNM/FA;
Carl Zeiss Meditec, Jena, Germany; or Optomap; Optos,
Dunfermline, UK). Spectral-domain optical coherence tomog-
raphy (SD-OCT; Heidelberg Engineering; Cirrus; Carl Zeiss
Meditec) was not available for cases with poor central fixation.
When possible, OCT volume scans were centered on the
retinal location used for fixation; line scans were centered at
the fovea. Central retinal thickness (CRT) and total macular
volume (TMV; employing the 1, 2.22, 3.45 mm ETDRS grid
centered on the fovea) were measured using the proprietary
OCT software. Full-field (ff) and multifocal (mf)ERGs were
recorded according to International Society for Clinical
Electrophysiology of Vision standards12,13 using an Espion
system (Diagnosys LLC, Lowell, MA, USA); the LKC system
(LKC Technologies, Inc. Gaithersburg, MD, USA); or a custom
ERG system.14 Full-field ERG was available in all but three
patients. Multifocal ERG using a 103- or 61-hexagon stimulus
array was possible in five patients who were able to maintain
steady central fixation. Optical coherence tomography and
ERG data were compared with age-matched normal values.
Kinetic visual fields were measured using the Goldmann
perimeter or the Octopus 900 perimeter (Haag Streit AG,
Switzerland).
Molecular Genetic Testing
Genetic testing was performed by high throughput, next
generation DNA sequencing using different platforms and
strategies from Clinical Laboratory Improvement Amend-
ments–approved laboratories (panel or whole exome sequenc-
ing). Bioinformatic data analysis, variant prioritization, and
confirmation of identified variants were done by Sanger
sequencing.2
RESULTS
Thirteen patients (seven female and six male) from 11 families
were identified with compound heterozygous (6/13 patients)
or homozygous (7/13 patients) mutations in the C2orf71 gene.
Consanguinity was identified in one family (ID# 13). The only
two families with two affected children were from Switzerland
and without known consanguinity or common ancestry.
Caucasian ethnicity was documented or presumed in 9 of 12
patients, with an additional patient being of mixed Caucasian/
Native American descent. One patient was of Korean and one
of mixed Lebanese/Armenian descent. No ethnicity was
recorded for the single remaining patient.
The mean age at which the clinical information was
documented was 32.1 years (range: 7–63 years). The main
symptom prompting the patients to seek an ophthalmologic
examination was reduced vision, with 6 of 12 (one not
documented) reporting nyctalopia. Awareness of nyctalopia
was reported during the second decade while symptoms of
photophobia were always denied. Myopia (mean:4.4 diopters
(D); range: 2.5 to 7.6 D) was observed in 8 of 12 patients.
Visual Function
Visual acuity ranged from 20/20 to light perception. Patients
typically maintained good central visual function with visual
acuity up to 20/40 or better in their third decade; however,
four patients (ID# 3, 4, 5, 6) experienced severe visual loss in
their third decade, from losing the ability to drive a car to
counting fingers or light perception. All of these four patients
described this vision loss as rapid over the course of a few
years. An atrophic maculopathy was observed in all four cases.
Visual field analysis showed concentric constriction initially
of the small isopters at ages 13 to the mid-20s, progressing to
ring scotomas and severely reduced visual fields after the age of
30 years.
Retinal function measured by ffERG in 11 patients showed
early impairment of both rod and cone function pointing to
severe retinal dysfunction, including at the youngest age
recorded (15 years; ID# 1, 11). These ERG changes were
variable, with cone more than rod dysfunction in three patients
where test results are available from a younger age (ID# 2, 11,
13) whereas other patients show equally reduced and delayed
rod and cone responses. The results of patients tested at an
older age (ID# 3, 5, 12) showed preferential reduction and
delay of the rod system or nonrecordable responses. The
youngest age at which ffERG responses were no longer
recordable was 26 years (ID# 6). Multifocal ERG recordings
were abnormal in all five available patients as early as age 15
years. In two patients (ID# 1, 2), mfERG testing was performed
twice, showing progressive loss of cone-mediated macular
function.
Retinal Morphology
Analysis of the 13 patients (including retinal assessments from
previous clinical examinations not shown here) shows a
progressive and symmetrical retinopathy starting with an early
mild maculopathy with a tapetoretinal sheen and wrinkling of
the internal limiting membrane. Patchy circular retinal RPE
atrophy was typically found in the midperipheral retina, and
may be placoid in appearance; however, bone spicule
pigmentation was rarely observed during the entire disease
course. Late-stage disease as diagnosed at age 32 (ID# 5) is
marked by extensive macular and peripheral chorioretinal
retinal atrophy with waxy optic discs. Intra- and interfamilial
variability in the severity of the phenotype was observed.
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FIGURE 1. Fundus photographs and corresponding AF images (when available) of all patients arranged by age. Comparison of fundus images of
patient #1 at ages 13 and 23 years demonstrate a progressive maculopathy and speckled macular AF at age 23. (A) Fundus images of patients #11 and
13 at age 17 and 20 years, respectively, show a mild maculopathy and corresponding central hypo-AF with surrounding hyper-AF (left eye AF not
shown). (B) Fundus images from patient #2 at age 22 and 25 years show a maculopathy and atrophic areas along the vascular arcade as well as hypo-
AF at age 25. (C) Panoramic fundus images of patient #10 at age 22 years illustrate mild maculopathy and speckled hypo AF. (D) A severe
maculopathy is visible on fundus images of patient #3, progressively worsening between ages 25 and 46 years. AF images show reduced AF in the
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The autofluorescence (AF) in C2orf71-related retinal
dystrophy shows perifoveal to macular hypo- and hyper-AF
rings at early stages (Fig. 1). At later disease stages, hypo-AF is
typically seen in areas of RPE atrophy. Spectral-domain OCT
demonstrates normal retinal lamination, but early disruption of
the ellipsoid zone and RPE irregularities (Fig. 2). Retinal layer
attenuation and reduced image quality due to eye movements
precluded reliable layer identification and quantification in all
but one patient. Manual retinal layer segmentation was only
possible on images obtained in one patient (ID# 2 at age 25)
that were compared with age-matched control data. Those
images revealed thinned inner and outer retinal layers without
a predilection of a specific retinal layer; therefore, segmenta-
tion supported the qualitative assessment of preserved but
universally thinned structure of the retinal layers. Analysis of
total macular volume (TMV) in both eyes of six patients aged
23 to 63 years, and with early to advanced disease stages,
showed a significant reduction even at a young age of 23 years.
Central retinal thickness (CRT) was less reduced compared to
TMV. Within the 3rd and 4th decade, CRT values demonstrated
FIGURE 1. Continued.
atrophic area and hypo- and hyper-AF over the entire fundus area imaged at age 46 years. (E) A progressive maculopathy and myopic optic disc
changes are shown in patient #6 at ages 26 and 33 years. (F) Maculopathy and midperipheral chorioretinal atrophy are shown in patient #5 at age 32
years. Corresponding AF demonstrates macular hypo-AF with a surrounding ring of hyper-AF and speckled hypo AF at the posterior pole. (G).
Scattered punctate deposits and patchy atrophy are visible in fundus images of patient #12 at age 44 years. Wide field AF shows extensive macular
hypo-AF with peripheral speckled hypo-AF sparing the midperiphery. (H) Advanced macular atrophy with extensive hypo-AF is shown in patient #7
at age 44. (I) Optic atrophy, chorioretinal atrophy, and hypo-AF are visible in patient #9 at age 47 years. (J) Extended chorioretinal atrophy but
relatively preserved optic disc is shown in the fundus images of patient #4 at age 50. (K) Placoid chorioretinal atrophy with thinned vessels and
waxy optic disc and large areas of hypo-AF are present on patient #8 at age 63 years (L).
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FIGURE 2. Spectral-domain OCT images of patients studied presented by eye pair in the order of age at imaging. Outer retinal dystrophy with
thinning of the photoreceptor layers, advancing with age, is demonstrated (A–L). Outer retinal tubulations are visible in the outer retina subfoveally
(both eyes of patient #12 [H]); extrafoveally (left eye of patient #9 [J]). (J) Open ORTs lacking a hyperreflective border on their outer aspects are
present in patient #9. (K) A so-called ‘‘forming ORT’’ with a free edge scrolling is visible in the left eye of patient #8.
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a slight to severe reduction as plotted in Figure 3. Abnormal
subfoveal changes in the outer retina were observed in both
eyes of patient #12 by SD-OCT. The ovoid tubular structures
with a partial hyperreflective border are visible within the
foveal region and resemble the previous description of
photoreceptor rosettes15 or outer retinal tubulation (ORT).16
Hyperreflective material within the ORT lumen was identified
in the left eye of patient #12. This could indicate preserved
inner segment ellipsoids and trapped retinal pigment.17 Note
that the tubular structures shown in Figure 2 lack hyper-
reflectivity on their outer aspects and are therefore called open
ORT. Extrafoveal open ORTs were visible in two other patients
(ID# 8, 9). In patient #9, the subfoveal OCT cross-section
shows a forming tubulation.
Mutational Analysis
We identified presumable compound heterozygous mutations
in six patients and presumable homozygous mutations in seven
patients in the C2orf71 gene. Eight of the mutations were
novel and seven have been described previously2–4,18,19 (Table
1). All of the 26 mutant alleles were truncation mutations (stop
gain, frameshift deletions, or insertions). This is consistent
with the high number of truncation mutations previously
identified in C2orf71 in retinal dystrophy patients (Source:
HGMD Professional).
Segregation Analysis
Segregation analysis was available in seven patients of five
families. In family 1, the mutations c.1709_1728del and
c.2227_2228del were identified in the unaffected mother and
FIGURE 3. Macular volume and central retinal thickness as a function
of age in patients with C2orf71 mutations showing significant volume
reduction in the presence of variable central thickness. Gray lines
show the 5% and 95% confidence interval of normative data.
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father, respectively. In family 2, both identified mutations
cosegregated with the disease and no unaffected family member
was available for testing. The mutation c.1206_1207dup was
identified in a heterozygous state in the unaffected mother of
patient #10. Other unaffected family members (father and two
siblings) were not available for testing. The mutation
c.2756_2768del was identified in the unaffected father and the
novel mutation c.802C>T was identified in the unaffected
mother of patient #11.
The novel mutation c.478_479insA was identified in the
unaffected mother and father of patient #13.
Haplotype Analysis Indicates Common Ancestry
The sequence variation NM_001029883.2: c.1709_1728del
(p.Gly570GlufsTer3) was identified in four Swiss patients from
two families (families 1 and 2), which suggests it to be more
abundant in the Swiss population. A common ancestry of these
patients could not be ascertained by information provided by
the patient’s family. Haplotype analysis in one affected patient
of one member of both family 1 (patient ID# 2; lab ID# 71703)
and family 2 (patient ID# 3; lab ID# 29870) supported the
C2orf71 location on the ‘‘p’’ arm of chromosome 2. This
analysis also revealed interesting results: out of 134 variants in
29,870 and 144 variants in 71,703 in RD genes on the ‘‘p’’ arm
of chromosome 2, 70 variants were common in both patients
(data not shown), in addition to the pathogenic frameshift
deletion. The sharing of almost of 50% of these variants in the
respective region is indicative of a shared ancestry in the two
patients and therefore two families of four affected patients.
DISCUSSION
This is the largest case series providing a detailed C2orf71
associated retinopathy phenotype characterization of the
C2orf71-associated retinopathy in 13 patients over a wide
range of ages. In all cases, C2orf71 mutations were associated
with signs and symptoms reminiscent of RP, except for the fact
that all had an early maculopathy and that less than half
complained of nyctalopia. Early macular pathology with cone-
mediated dysfunction was associated with reduced vision at an
early disease stage. Follow-up data were available only in a few
individual patients.
The spectrum of changes seen on fundus appearance, as
demonstrated in Figure 1, ranges from early onset maculopathy
(patients #1, 2, and 11) to RP-like (e.g., patients #6, 10, and 12)
or choroideremia-like (patients #4 and 8) chorioretinal
changes. Microstructural loss of photoreceptor integrity and
retinal layer atrophy with maintained laminar structure, even in
the late stages of disease, point to a primary photoreceptor
disease process. The degenerative sign of ORT in the region of
less severely affected central macula or at the ‘‘junctional
zone’’ of advanced to less-advanced disease severity was
identified in three of the reported patients. Outer retinal
tubulations have been described in various retinal degenerative
disorders and can be found in closed and open forms.16,20–24
Analysis by SD-OCT and adaptive optics imaging together with
histopathologic studies point to degenerative cones with
remnant or absent outer segments and inner segments with
small and dispersed organelles as a source of high reflectivity
around the ORT.15,17,21,25 It is proposed that the rosette
arrangement promotes survival of degenerative photoreceptor
cells.16 It is of particular note that visual acuity appears to be
less reduced in all three patients with visible ORT, despite the
older ages of these patients relative to the cohort as a whole.
Hyperreflective material within the ORT lumen is one of the
major features of ORT and could be identified in one patient
(#12). These luminal contents may indicate preserved inner
segment ellipsoids. The subfoveal location of the ORT in
patient #12 could potentially explain the preserved visual
acuity in this patient. Histologic studies have shown the
presence of RPE and other cells within the ORT lumen, which
might provide trophic support to photoreceptors.21
FIGURE 4. Pedigrees and segregation of available families (families 1, 2 8, 9, and 11).
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Although visual deterioration usually occurs in the second
to third decade, some useful vision can be retained up to the
fifth or sixth decade. Advanced retinal dysfunction, as
evidenced by ERG findings, was present at the first visit,
indicating early disease onset, even before symptoms lead
patients to seek medical attention. The electroretinogram
results in our patient cohort point to an early-onset severe
reduction of rod-cone or cone-rod function. This supports a
previous report by Hebrard et al.5 where two patients had
onset of symptoms during the third decade together with
documentation of severely abnormal ERG responses and a
visible maculopathy. Retinal dysfunction seems to be more
pronounced in the cone- than in the rod-driven pathway at a
younger age, which was also observed in the recordable ERG
data by others.4–6 However, the very low response amplitudes
available in our data set are insufficient to predict which
photoreceptor pathway, cone- or rod driven, is more affected
at an early age (such as in the first decade). Macular cone
function might be earlier affected and more vulnerable than
peripheral cones, which would explain the severely reduced
mfERG responses and reduction in visual function. Earlier
disease detection together with efficient and widely available
molecular genetic testing will guide the understanding of
C2orf71-related retinal dysfunction throughout its natural
course.
The C2orf71 protein localization within the photoreceptor
outer segments or connecting cilium1 likely explains the
photoreceptor degeneration as seen in several other ciliopa-
thies, syndromic or not. Ciliopathies can range from severe
morphogenic malformations to nonsyndromic early or late
onset with photoreceptor degeneration.26 The spectrum of
retinal degeneration in ciliopathies is variable, including severe
congenital dysfunction such as Leber congenital amaurosis
(LCA) caused by mutations in CEP290, and progressive
moderate to severe visual dysfunction (Usher syndrome,
Bardet-Biedl syndrome, X-linked RP caused by RPGR muta-
tion). The systemic signs observed in other ciliopathies (e.g.,
digit or kidney anomalies, hearing, neurological or cognitive
impairment)2728,29 have to date not been recorded in patients
with C2orf71 mutations.
Expression of C2orf71is restricted to the photoreceptors
and the protein includes a 72–amino acid long proline-rich
domain at the carboxyl terminus. These properties are quite
similar to another retinal dystrophy associated gene AIPL1,
which is associated with juvenile RP, LCA, and cone-rod
dystrophy. Such domains have been shown to play important
roles as common binding motifs and in biological processes
involving rapid exchange and involvement of several proteins
such as signaling cascades and transcription.30
We found eight novel mutations in C2orf71, all of which are
nonsense or frameshift mutations. Consistent with published
data, the mutations reported in this study comprise protein
truncation mutations such as nonsense mutations and frame-
shift deletions and insertions. Interestingly, all of these
mutations occurred in exon 1 of the gene. The nonsense and
frameshift mutations are predicted to lead to nonsense-
mediated decay. All cases were presumably or confirmed
homozygous or compound heterozygous for nonsense and/or
frameshift mutations. Thus truncating mutations, most likely
leading to nonsense mediated decay of the messenger RNA, are
the predominant pathogenic DNA sequence variation type in
this study (>86%). This is higher than published numbers
(HGMD Professional), in which about 67% of pathogenic
sequence variants lead to truncating variations. There was no
obvious genotype-phenotype correlation difference within the
patients with truncating mutations. The majority of C2orf71
mutations reported to date have been identified in Caucasian
patients. To our knowledge, this is the first report of C2orf71
mutations in a Korean patient.
In summary, this is the largest series of patients (n ¼ 13)
with C2orf71-related retinopathy in which eight novel
C2orf71 mutations were identified and the related structural
and functional phenotypes defined. Together with 35 previ-
ously reported mutations entered in HGMD, C2orf71 might
represent one of the more frequently mutated gene in
autosomal recessive RP, preceded by EYS, USH2A, CRB1, and
PDE6B, making it more frequent than the contribution of
mutations in RPE65, ABCA4 (not including the ‘classic’
Stargardt phenotype), MERTK or TULP1 in some populations
such as in Switzerland. Although no pathognomonic features
were identified, all patients had a slowly progressive photore-
ceptor degeneration with an early onset maculopathy and
structural changes such as ORT. Useful vision is usually
preserved until the 30s and may be preserved longer in some
cases. These findings may have implications for potential
therapeutic approaches; treatment before the age of 25 will
likely offer the best opportunities as the central visual function
deteriorates quickly afterwards.
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